Key facts
- Syngenta aims for a valuation of at least $66 billion in its Hong Kong IPO.
- The company is pitching its flotation at a multiple of 15 to 20 times its 2026 EBITDA.
- Syngenta posted $4.4 billion in EBITDA in 2025, up 17% year-on-year.
Syngenta's advisers are targeting a valuation of at least $66 billion for the agrochemical company's Hong Kong market listing, which is expected to be completed early next year. The company, controlled by Chinese state-owned firm Sinochem, is pitching its flotation at a multiple of 15 to 20 times its 2026 earnings before interest, tax, depreciation and amortisation (EBITDA). In 2025, Syngenta posted EBITDA of $4.4 billion, a 17% increase from a year earlier. UBS and CICC are promoting the IPO, which is expected to be among the world's biggest. China CITIC Bank and Bank of America are also assisting.